Tenet Healthcare (THC) Tops Q4 EPS by 68c ; Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $4.70, $0.68 better than the analyst estimate of $4.02. Revenue for the quarter came in at $5.53 billion versus the consensus estimate of $5.47 billion.

GUIDANCE:

Tenet Healthcare sees FY2026 EPS of $16.19-$18.47, versus the consensus of $16.46. Tenet Healthcare sees FY2026 revenue of $21.5-22.3 billion, versus the consensus of $22.21 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Offerpad to move stock listing from NYSE to Nasdaq